Your browser doesn't support javascript.
loading
Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and/or anti-SARS-CoV-2.
Antar, Samar A; Saleh, Mohamed A; Al-Karmalawy, Ahmed A.
Affiliation
  • Antar SA; Department of Pharmacology and Biochemistry, Faculty of Pharmacy, Horus University, New Damietta 34518, Egypt. Electronic address: santar@horus.edu.eg.
  • Saleh MA; Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah 27272, the United Arab Emirates; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.
  • Al-Karmalawy AA; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Ahram Canadian University, 6th of October City, Giza 12566, Egypt. Electronic address: akarmalawy@acu.edu.eg.
Life Sci ; 309: 121048, 2022 Nov 15.
Article in En | MEDLINE | ID: mdl-36209833
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transforming Growth Factor beta1 / COVID-19 Drug Treatment Limits: Humans Language: En Journal: Life Sci Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transforming Growth Factor beta1 / COVID-19 Drug Treatment Limits: Humans Language: En Journal: Life Sci Year: 2022 Document type: Article Country of publication: